Compliance Services Partner John Brownlee will speak at a Food and Drug Law Institute conference titled, "Enforcement and Litigation Conference: FDA Enforcement – More Individuals, More Often."
Two recent developments in FDA enforcement policy are meaningful for officials at food, drug, medical device and tobacco firms. First, as part of a more aggressive enforcement attitude, FDA officials have announced that they will likely be prosecuting responsible corporate officers for strict liability offenses of the Federal Food, Drug, and Cosmetic Act (FDCA) under the Park doctrine. Second, FDA recently initiated two debarment proceedings against individuals who had been convicted of misdemeanor violations of the FDCA.
In addition to discussing how these developments will translate to FDA enforcement actions, the conference will include:
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.